Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Sunday, December 27, 2009, 1:39PM ET - U.S. Markets Closed. Dow Up 0.51% Nasdaq Up 0.71%
Catalyst Pharmaceutical Partners Inc. (CPRX)On Dec 24: 0.63  Down 0.03 (4.55%)  
MORE ON CPRX
Quotes
Charts
News & Info
Company
HereIndustry
Analyst Coverage
Ownership
Financials

Industry: Drugs - GenericGet Industry for:
CPRX SECTOR / INDUSTRY MEMBERSHIP
Sector:Healthcare
Industry:Drugs - Generic
INTRADAY PERFORMANCE SUMMARY
NameTickerChange
Chart for Catalyst Pharmaceutical Partners Inc. (CPRX)
Catalyst Pharmaceutical Partners Inc.CPRXDown 4.55%
Drugs - Generic^YHOh785 0.00%
View Drugs - Generic Industry Center
DRUGS - GENERIC INDUSTRY NEWS
Ranbaxy Unit Gets FDA Warning
Thu 8:22 AM - at The Wall Street Journal Online
Vytorin Update: Cancer Risk, Generic Challenge
Tue 1:58 PM - at The Wall Street Journal Online
Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories' New Drug Application (NDA) for Efavirenz Tablets
Tue 8:00 AM - PR Newswire
Mylan sued over plans for generic Vytorin
Tue 7:31 AM - AP
Mylan Confirms First-to-File Patent Challenge Relating to Vytorin(R) Cholesterol Medication
Tue 7:00 AM - PR Newswire
According To Credit Suisse Vice President, Certain Health Care Stocks To Benefit Greatly From U.S. Legislation: Which Companies Stand To Benefit The Most?
Mon 5:40 PM - Wall Street Transcript
More Industry News...

TOP DRUGS - GENERIC COMPANIES BY MARKET CAP
CompanySymbolPriceChangeMarket CapP/E
Mylan, Inc.MYL18.74 0.00%5.73B114.97
Watson Pharmaceuticals Inc.WPI39.91Up 0.28%4.24B20.57
Par Pharmaceutical Companies Inc.PRX26.52Down 0.11%923.40M23.74
Hi Tech Pharmacal Co. Inc.HITK27.06Down 0.48%326.91M13.63
Caraco Pharmaceutical Laboratories Ltd.CPD5.92Down 1.82%231.41MN/A
Catalyst Pharmaceutical Partners Inc.CPRX0.63Down 4.55%11.36MN/A
Showing 1 - 5 of 9 - View All
More Top Companies: by Performance, by Valuation, by Growth, more...
CPRX VS. INDUSTRY LEADERS
Statistic Industry Leader CPRXCPRX Rank
Market CapitalizationMYL5.73B11.36M9 / 9
P/E Ratio (ttm)MYL114.97N/A N/A
PEG Ratio (ttm, 5 yr expected)WPI1.89N/A N/A
Revenue Growth (Qtrly YoY)HLCS451.00% N/A N/A
EPS Growth (Qtrly YoY)HITK547.90% N/A N/A
Long-Term Growth Rate (5 yr)PRX53.2%N/A N/A
Return on Equity (ttm)HITK24.19%-104.30%7 / 9
Long-Term Debt/Equity (mrq) N/A
Dividend Yield (annual)N/A N/A
View Leaders & Laggards
MORE ON DRUGS - GENERIC
Industry Summary
News
Leaders & Laggards
Company List
Industry Calendar
RELATED INDUSTRIES
Biotechnology
Diagnostic Substances
Drug Delivery
Drug Manufacturers - Major
Drug Manufacturers - Other
Drug Related Products
Top Performing Industries | Complete Industry List

Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
Get Industry for Another Symbol: Symbol Lookup
Research Reports ScreenerIndustry Center